Content
10/17/2023 San Jose, CA USA
Evident Vascular completed $35 million Series A Round funding. Investors include Vensana Capital.
#MedTech  
About
Evident Vascular, Inc., is developing an advanced intravascular ultrasound (IVUS) platform technology designed initially for peripheral vascular interventions, with future capability for coronary procedures. Leveraging artificial intelligence (AI) to enable superior image interpretation and streamlined workflows, Evident Vascular’s technology has been designed to expand adoption of IVUS, driving increased market penetration and enabling improved clinical outcomes with faster, more accurate diagnosis and treatment decisions.
Startup
Evident Vascular
https://evidentvascular.com Claim Profile
Location:
San Jose, CA USA
Sector:
MedTech
Download StockFan App Ad
Stock market data, news and community, all integrated.
Features include real time stock quotes, interactive charts, technical signals, institutional & insider ownerships, stock screener, ETF rankings, SEC filings, press releases, videos, earnings calendar, social media posts, group chats.